Skip Navigation


Bioinformatics Advance Access originally published online on February 12, 2004
This Article
Right arrow FREE Full Text (Print PDF) Freely available
Right arrow FREE Full Text (Screen PDF)
Right arrow All Versions of this Article:
20/9/1388    most recent
bth100v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nielsen, M.
Right arrow Articles by Lund, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nielsen, M.
Right arrow Articles by Lund, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Bioinformatics 20(9) © Oxford University Press 2004; all rights reserved.

Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach

Morten Nielsen 1,*, Claus Lundegaard 1, Peder Worning 1, Christina Sylvester Hvid 2, Kasper Lamberth 2, Søren Buus 2, Søren Brunak 1 and Ole Lund 1

1 Center for Biological Sequence Analysis, BioCentrum-DTU, Building 208, Technical University of Denmark, DK-2800 Lyngby, Denmark and 2 Department of Experimental Immunology, Institute of Medical Microbiology and Immunology, Panum Building 18.3.22, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark

Received on August 29, 2003; revised on November 21, 2003; accepted on December 9, 2003
Advance Access Publication February 12, 2004

Motivation: Prediction of which peptides will bind a specific major histocompatibility complex (MHC) constitutes an important step in identifying potential T-cell epitopes suitable as vaccine candidates. MHC class II binding peptides have a broad length distribution complicating such predictions. Thus, identifying the correct alignment is a crucial part of identifying the core of an MHC class II binding motif. In this context, we wish to describe a novel Gibbs motif sampler method ideally suited for recognizing such weak sequence motifs. The method is based on the Gibbs sampling method, and it incorporates novel features optimized for the task of recognizing the binding motif of MHC classes I and II. The method locates the binding motif in a set of sequences and characterizes the motif in terms of a weight-matrix. Subsequently, the weight-matrix can be applied to identifying effectively potential MHC binding peptides and to guiding the process of rational vaccine design.

Results: We apply the motif sampler method to the complex problem of MHC class II binding. The input to the method is amino acid peptide sequences extracted from the public databases of SYFPEITHI and MHCPEP and known to bind to the MHC class II complex HLA-DR4(B1*0401). Prior identification of information-rich (anchor) positions in the binding motif is shown to improve the predictive performance of the Gibbs sampler. Similarly, a consensus solution obtained from an ensemble average over suboptimal solutions is shown to outperform the use of a single optimal solution. In a large-scale benchmark calculation, the performance is quantified using relative operating characteristics curve (ROC) plots and we make a detailed comparison of the performance with that of both the TEPITOPE method and a weight-matrix derived using the conventional alignment algorithm of ClustalW. The calculation demonstrates that the predictive performance of the Gibbs sampler is higher than that of ClustalW and in most cases also higher than that of the TEPITOPE method.

Contact: mniel{at}cbs.dtu.dk

* To whom correspondence should be addressed.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. A. McCormick, S. Reddy, S. J. Reinl, T. I. Cameron, D. K. Czerwinkski, F. Vojdani, K. M. Hanley, S. J. Garger, E. L. White, J. Novak, et al.
Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study
PNAS, July 22, 2008; 105(29): 10131 - 10136.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C. Lundegaard, K. Lamberth, M. Harndahl, S. Buus, O. Lund, and M. Nielsen
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Nucleic Acids Res., July 1, 2008; 36(suppl_2): W509 - W512.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
M. L. Miller, S. Hanke, A. M. Hinsby, C. Friis, S. Brunak, M. Mann, and N. Blom
Motif Decomposition of the Phosphotyrosine Proteome Reveals a New N-terminal Binding Motif for SHIP2
Mol. Cell. Proteomics, January 1, 2008; 7(1): 181 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Chentoufi, X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M. Wu, X. Zhu, A. Mohebbi, S. Buus, et al.
HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D
J. Immunol., January 1, 2008; 180(1): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
C. Lundegaard, O. Lund, C. Kesmir, S. Brunak, and M. Nielsen
Modeling the adaptive immune system: predictions and simulations
Bioinformatics, December 15, 2007; 23(24): 3265 - 3275.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
C.-W. Tung and S.-Y. Ho
POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties
Bioinformatics, April 15, 2007; 23(8): 942 - 949.
[Abstract] [Full Text] [PDF]


Home page
Brief BioinformHome page
J. C. Tong, T. W. Tan, and S. Ranganathan
Methods and protocols for prediction of immunogenic epitopes
Brief Bioinform, March 1, 2007; 8(2): 96 - 108.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. T. Chang, D. Ghosh, D. E. Kirschner, and J. J. Linderman
Peptide length-based prediction of peptide-MHC class II binding
Bioinformatics, November 15, 2006; 22(22): 2761 - 2767.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
P. Haste Andersen, M. Nielsen, and O. Lund
Prediction of residues in discontinuous B-cell epitopes using protein 3D structures
Protein Sci., November 1, 2006; 15(11): 2558 - 2567.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Donnes and O. Kohlbacher
SVMHC: a server for prediction of MHC-binding peptides.
Nucleic Acids Res., July 1, 2006; 34(Web Server issue): W194 - W197.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
S. Zhu, K. Udaka, J. Sidney, A. Sette, K. F. Aoki-Kinoshita, and H. Mamitsuka
Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules
Bioinformatics, July 1, 2006; 22(13): 1648 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. A. Reche and E. L. Reinherz
PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands
Nucleic Acids Res., July 1, 2005; 33(suppl_2): W138 - W142.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
P. A. Reche, H. Zhang, J.-P. Glutting, and E. L. Reinherz
EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology
Bioinformatics, May 1, 2005; 21(9): 2140 - 2141.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.